By using this site, you agree to our Privacy Policy and our Terms of Use. Close

Honestly, their stock was rather modestly priced considering their forecast (which explains the relatively miniscule drop despite these somewhat dissapointing news). Like I've already stated in this thread though, they beat their forecast when exclusing impairment charges. Seems like they just wanted to get it over with so that it wouldn't reflect badly upon FY16.

Now I'm looking forward to per segment results.